Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML
Clinical trial NCT02306291 · COMPLETED
Trial details
- NCT number
- NCT02306291
- Sponsor
- GlycoMimetics Incorporated
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2017-12-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.